‘Turnaround Kid’ Is Tapped to Lead OxyContin Maker's Board
- Purdue Pharma brings in restructuring expert, new top lawyer
- Drugmaker trying to transform amid sprawling opioid litigation
Photographer: Bill Oxford/iStockphoto via Getty Images
This article is for subscribers only.
Purdue Pharma LP is bringing in a famous figure in corporate restructuring as the Oxycontin maker tries to overhaul its business and distance itself from the U.S. opioid crisis.
Steve Miller, 76, will become chairman of the company’s board effective Tuesday. Miller, author of a 2008 memoir titled “The Turnaround Kid: What I Learned Rescuing America’s Most Troubled Companies,” helped lead auto-parts maker Delphi Corp. through bankruptcy and served as chairman of American International Group Inc. as the insurer worked to repay its federal bailout after the financial crisis.